Breast and Cervical Cancer Early Detection and Control Advisory Committee, 20754-20755 [05-7992]

Download as PDF 20754 Federal Register / Vol. 70, No. 76 / Thursday, April 21, 2005 / Notices Intermediaries, Federal Maritime Commission, Washington, DC 20573. Non-Vessel—Operating Common Carrier Ocean Transportation Intermediary Applicants: Regal Shipping Inc. dba Sealines International dba Shipping Line, 333 Southern Blvd., Suite 404, West Palm Beach, FL 33405. Officer: Edward T. Nevins, President (Qualifying Individual). Inter-Continental Trading, Inc. dba Yuan Mao Logistics dba InterContinental Trading Group, Inc., 1224 Santa Anita Avenue, #F, South El Monte, CA 91733. Officers: Shun Li, Secretary (Qualifying Individual), Cheng Zhou, Zhou, President. Non-Vessel-Operating Common Carrier and Ocean Freight Forwarder Transportation Intermediary Applicants: Interport Freight Services, Inc., 370 McClellan Highway, East Boston, MA 02128. Officer: Joseph D’Urso, President (Qualifying Individual). Sea Shipping Line (California) Inc., 9401 San Leandro Street, Oakland, CA 94683. Officers: Frank Rosenberg, President (Qualifying Individual), Fred Morgenthaler, Secretary. Ocean Freight Forwarder—Ocean Transportation Intermediary Applicants: UCB Logistics, Inc., 5777 W. Century Blvd., Suite 590, Los Angeles, CA 90045. Officers: Robert A. Carranza, Vice President (Qualifying Individual), Young S. Chang, President. Traffich Tech International, US, LLC, Crystal Plaza One, 2001 Jefferson Davis Highway, Suite 1111, Arlington, VA 22202. Officer: Collin Anday, Director (Qualifying Individual). Dated: April 15, 2005. Bryant L. VanBrakle, Secretary. [FR Doc. 05–7956 Filed 4–20–05; 8:45 am] assets or the ownership of, control of, or the power to vote shares of a bank or bank holding company and all of the banks and nonbanking companies owned by the bank holding company, including the companies listed below. The applications listed below, as well as other related filings required by the Board, are available for immediate inspection at the Federal Reserve Bank indicated. The application also will be available for inspection at the offices of the Board of Governors. Interested persons may express their views in writing on the standards enumerated in the BHC Act (12 U.S.C. 1842(c)). If the proposal also involves the acquisition of a nonbanking company, the review also includes whether the acquisition of the nonbanking company complies with the standards in section 4 of the BHC Act (12 U.S.C. 1843). Unless otherwise noted, nonbanking activities will be conducted throughout the United States. Additional information on all bank holding companies may be obtained from the National Information Center Web site at www.ffiec.gov/nic/. Unless otherwise noted, comments regarding each of these applications must be received at the Reserve Bank indicated or the offices of the Board of Governors not later than May 13, 2005. A. Federal Reserve Bank of Atlanta (Andre Anderson, Vice President) 1000 Peachtree Street, NE., Atlanta, Georgia 30303: 1. Tombigbee Bancshares, Inc., Sweet Water, Alabama; to become a bank holding company by acquiring 100 percent of the voting shares of Sweet Water State Bank, Sweet Water, Alabama. Board of Governors of the Federal Reserve System, April 15, 2005. Robert deV. Frierson, Deputy Secretary of the Board. [FR Doc. 05–7980 Filed 4–20–05; 8:45 am] BILLING CODE 6210–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES BILLING CODE 6730–01–P Centers for Disease Control and Prevention FEDERAL RESERVE SYSTEM Formations of, Acquisitions by, and Mergers of Bank Holding Companies Healthcare Infection Control Practices Advisory Committee: Notice of Charter Renewal The companies listed in this notice have applied to the Board for approval, pursuant to the Bank Holding Company Act of 1956 (12 U.S.C. 1841 et seq.) (BHC Act), Regulation Y (12 CFR Part 225), and all other applicable statutes and regulations to become a bank holding company and/or to acquire the This gives notice under the Federal Advisory Committee Act (Pub. L. 92– 463) of October 6, 1972, that the Healthcare Infection Control Practices Advisory Committee, Centers for Disease Control and Prevention, of the Department of Health and Human Services, has been renewed for a 2-year VerDate jul<14>2003 14:55 Apr 20, 2005 Jkt 205001 PO 00000 Frm 00025 Fmt 4703 Sfmt 4703 period extending through January 19, 2007. For Further Information Contact: Michele Pearson, M.D., Executive Secretary, Healthcare Infection Control Practices Advisory Committee, Centers for Disease Control and Prevention, of the Department of Health and Human Services, 1600 Clifton Road, NE., M/S E–68, Atlanta, Georgia 30333, telephone 404–498–1266 or fax 404–498–1244. The Director, Management and Analysis and Services office has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Dated: April 14, 2005. Alvin Hall, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 05–7993 Filed 4–20–05; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Breast and Cervical Cancer Early Detection and Control Advisory Committee In accordance with section 10(a)(2)of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the following committee meeting: Name: Breast and Cervical Cancer Early Detection and Control Advisory Committee (BCCEDCAC). Times and Dates: 8:30 a.m.–5 p.m., May 3, 2005. 8:30 a.m.–3 p.m., May 4, 2005. Place: Omni CNN Center Hotel, 100 CNN Center, Atlanta, Georgia, 30303 Phone: 404– 659–0000. Status: Open to the public, limited only by the space available. Purpose: The committee is charged with advising the Secretary, Department of Health and Human Services, and the Director, CDC, regarding the early detection and control of breast and cervical cancer. The committee makes recommendations regarding national program goals and objectives; implementation strategies; and program priorities including surveillance, epidemiologic investigations, education and training, information dissemination, professional interactions and collaborations, and policy. Matters To Be Discussed: The agenda will include discussion and review of National Cancer Prevention and Control Program E:\FR\FM\21APN1.SGM 21APN1 Federal Register / Vol. 70, No. 76 / Thursday, April 21, 2005 / Notices Highlights; overview of USCS Report; update of the National Report; update of expert panel meetings; Performance based budgeting; providing Mammography Screening for younger Women; getting the facts on Tribal & Territories NBCCEDP Program; using data to drive program planning; serving American Indian Populations; Coalition; Partnership & Collaboration; Survivorship; Case Management Evaluation. Agenda items are subject to change as priorities dictate. For More Information Contact: Debra Younginer, Executive Secretary, BCCEDCAC, Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, CDC, 4770 Buford Highway, Mailstop K–57, Chamblee, Georgia 30316, Telephone: 770–488–1074. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: April 15, 2005. Alvin Hall, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 05–7992 Filed 4–20–05; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention National Center for Injury Prevention and Control Initial Review Group In accordance with section 10(a) (2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers For Disease Control and Prevention (CDC) announce the following meeting: Name: National Center for Injury Prevention and Control (NCIPC), Initial Review Group (IRG). Time and Date: 1 p.m.–5 p.m., May 20, 2005. Place: The conference call will originate at the National Center for Injury Prevention and Control, in Atlanta, Georgia. Status: Closed: 1 p.m.–5 p.m., May 20, 2005. Purpose: This group is charged with providing advice and guidance to the Secretary of Health and Human Services and the Director, CDC, concerning the scientific and technical merit of grant and cooperative agreement applications received from academic institutions and other public and private profit and nonprofit organizations, including State and local government agencies, to conduct specific injury research that focuses on prevention and control and supports Injury Control Research Centers (ICRCs). VerDate jul<14>2003 14:55 Apr 20, 2005 Jkt 205001 Matters to be Discussed: Agenda items include an overview of the injury program, discussion of the review process and panelists’ responsibilities, and the review of and vote on applications. From 1 p.m. to 5 p.m., May 20, the Group will review individual research cooperative agreement in response to announcements: #05098, Research in Areas of Acute Care, Disability, and Rehabilitation at the Notre Dame Center for Orthopedic Research and Engineering; #05099, University of Oklahoma Health Sciences Center, Developmental Injury Prevention Research Center; #05100, National Foundation for Trauma Care: The Study of the Impact of a Terrorist Attack on Individual Trauma Centers; #05101, Pennsylvania Chapter of the American College of Emergency Physicians; #05106, Iowa State University, Center for the Study of Violence. This meeting will be closed to the public in accordance with provisions set forth in section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Pub. L. 92–463. Agenda items are subject to change as priorities dictate. Contact Person for More Information: Gwendolyn H. Cattledge, Ph.D., M.S.E.H., Executive Secretary, NCIPC IRG, CDC, 4770 Buford Highway, NE., M/S K02, Atlanta, Georgia 30341–3724, telephone (770) 488– 4655. The Director, Management Analysis and Services Office has been delegated the authority to sign Federal Register Notices pertaining to announcements of meetings and other committee management activities for both CDC and Prevention and the Agency for Toxic Substances and Disease Registry. Dated: April 15, 2005. Alvin Hall, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 05–7995 Filed 4–20–05; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention National Center for Injury Prevention and Control Initial Review Group In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announce the following meeting: Name: National Center for Injury Prevention and Control (NCIPC), Initial Review Group (IRG). Times and Dates: 12:30 p.m.–5:30 p.m., May 18, 2005. 12:30 p.m.–5:30 p.m., May 19, 2005. Place: The conference call will originate at the National Center for Injury Prevention and Control, in Atlanta, Georgia. PO 00000 Frm 00026 Fmt 4703 Sfmt 4703 20755 Status: Closed: 12:30 p.m.–5:30 p.m., May 18, 2005. Closed: 12:30 p.m.–5:30 p.m., May 19, 2005. Purpose: This group is charged with providing advice and guidance to the Secretary of Health and Human Services and the Director, CDC, concerning the scientific and technical merit of grant and cooperative agreement applications received from academic institutions and other public and private profit and nonprofit organizations, including State and local government agencies, to conduct specific injury research that focuses on prevention and control and supports Injury Control Research Centers (ICRCs). Matters to be Discussed: Agenda items include an overview of the injury program, discussion of the review process and panelists’ responsibilities, and the review of and vote on applications. Beginning at 12:30 p.m., May 18, through 5:30 p.m., May 19, the Group will review individual research cooperative agreement in response to announcement: #05020, Youth Violence through Community-Level Change. This meeting will be closed to the public in accordance with provisions set forth in section 552b(c)(4) and (6), title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Pub. L. 92–463. Agenda items are subject to change as priorities dictate. For Further Information Contact: Gwendolyn H. Cattledge, Ph.D., M.S.E.H., Executive Secretary, NCIPC IRG, CDC, 4770 Buford Highway, NE., M/S K02, Atlanta, Georgia 30341–3724, telephone 770–488– 4655. The Director, Management Analysis and Services Office has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities for both CDC and Prevention and the Agency for Toxic Substances and Disease Registry. Dated: April 15, 2005. Alvin Hall, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 05–7989 Filed 4–20–05; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention National Institute for Occupational Safety and Health Advisory Board on Radiation and Worker Health In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the following committee meeting: E:\FR\FM\21APN1.SGM 21APN1

Agencies

[Federal Register Volume 70, Number 76 (Thursday, April 21, 2005)]
[Notices]
[Pages 20754-20755]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-7992]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Breast and Cervical Cancer Early Detection and Control Advisory 
Committee

    In accordance with section 10(a)(2)of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following committee meeting:

    Name: Breast and Cervical Cancer Early Detection and Control 
Advisory Committee (BCCEDCAC).
    Times and Dates: 8:30 a.m.-5 p.m., May 3, 2005. 8:30 a.m.-3 
p.m., May 4, 2005.
    Place: Omni CNN Center Hotel, 100 CNN Center, Atlanta, Georgia, 
30303 Phone: 404-659-0000.
    Status: Open to the public, limited only by the space available.
    Purpose: The committee is charged with advising the Secretary, 
Department of Health and Human Services, and the Director, CDC, 
regarding the early detection and control of breast and cervical 
cancer. The committee makes recommendations regarding national 
program goals and objectives; implementation strategies; and program 
priorities including surveillance, epidemiologic investigations, 
education and training, information dissemination, professional 
interactions and collaborations, and policy.
    Matters To Be Discussed: The agenda will include discussion and 
review of National Cancer Prevention and Control Program

[[Page 20755]]

Highlights; overview of USCS Report; update of the National Report; 
update of expert panel meetings; Performance based budgeting; 
providing Mammography Screening for younger Women; getting the facts 
on Tribal & Territories NBCCEDP Program; using data to drive program 
planning; serving American Indian Populations; Coalition; 
Partnership & Collaboration; Survivorship; Case Management 
Evaluation.
    Agenda items are subject to change as priorities dictate.
    For More Information Contact: Debra Younginer, Executive 
Secretary, BCCEDCAC, Division of Cancer Prevention and Control, 
National Center for Chronic Disease Prevention and Health Promotion, 
CDC, 4770 Buford Highway, Mailstop K-57, Chamblee, Georgia 30316, 
Telephone: 770-488-1074.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities for both CDC and the Agency for Toxic Substances and 
Disease Registry.

    Dated: April 15, 2005.
Alvin Hall,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 05-7992 Filed 4-20-05; 8:45 am]
BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.